Mar. 21 at 7:54 PM
$CAPR
In my experience there are two major catalysts that really boost a share price.
The first is a drug approval. Capricor's share price will soon receive a very large boost when the FDA approves Deramiocel. Most of us agree that this approval will come far before the August 22 PDUFA date. It literally could come any day!
The second major catalyst is a partnership. Capricor already has a partnership with NS for the US and Japan. There will be over
$700 million coming in milestones from this partnership.
But there is a new partnership for Europe which could be announced any day for over another
$700 million.
And we are told to expect "several" StealthX exosome Therapeutic drug delivery partnerships in 2027. Nice!
